As we had found that treatment of melanoma cells with GSPs resulted in suppression of miR-106b (Fig. 3A ' 3B), we further determined whether treatment of GSPs upregulate or reactivate the expression of p21/WAF1/Cip1 in melanoma cells. This evidence concerns the gene CDKN1A and melanoma.